Oxford Drug Design revenue hit $1.4M in 2024

Oxford Drug Design generates revenue from customers

Oxford Drug Design

Oxford, United Kingdom

About Company RevenueFundingTeamFounder/CEOCEO Net Worth

How Oxford Drug Design hit $1.4M revenue with a 11 person team in 2023.

InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.

Founded

2001

Founded

Revenue

$1.4M

2023 Revenue

YOY

25.66%

YOY

Funding

$12.4M

Funding

Oxford Drug Design Revenue

In 2023, Oxford Drug Design revenue run rate hit $1.4M in revenue.

  • 2023

    Oxford Drug Design hit $1.4M in revenue in 2023

  • 2022

    Oxford Drug Design hit $1.1M in revenue in 2022

  • 2022

    Oxford Drug Design hit $1.1M in revenue in 2022

  • 2021

    Oxford Drug Design hit $709.9K in revenue in 2021

  • 2021

    Oxford Drug Design hit $709.9K in revenue in 2021

  • 2001

    Oxford Drug Design launched in 2001 with $0 revenue

Oxford Drug Design Funding History

  • 2022 Convertible Note

    Oxford Drug Design raised a Convertible Note of in May, 2022

  • 2019 Grant

    Oxford Drug Design raised a Grant of in November, 2019

  • 2019 Venture Round

    Oxford Drug Design raised a Venture Round of in November, 2019

  • 2019 Grant

    Oxford Drug Design raised a Grant of in May, 2019

  • 2017 Series A

    Oxford Drug Design raised a Series A of in April, 2017

  • 2006 Venture Round

    Oxford Drug Design raised a Venture Round of in November, 2006

FUNDING DATE ROUND AMOUNT VALUATION
May, 19 2022 Convertible Note
November, 06 2019 Grant
November, 06 2019 Venture Round
May, 01 2019 Grant
April, 01 2017 Series A
November, 17 2006 Venture Round

Team

Oxford Drug Design has 11 total employees. an engineering team of 2 and a marketing team of 1.

DISTRIBUTION QTY
Total team size 11
Engineer 2 (18%)
Marketing 1 (9%)

Founder / CEO

Graham Richards

Q&A

  • What's your age?

    -

  • Favorite online tool?

    -

  • Favorite book?

    -

  • Favorite CEO?

    -

  • Advice for 20 year old self

    -

Customers

Churn

Oxford Drug Design Executives

Name Position Working Email Personal Email
Graham Richards CEO - -

Oxford Drug Design Employees

Name Position Working Email Personal Email
Graham Richards CEO - -

Frequently Asked Questions about Oxford Drug Design

  • When was Oxford Drug Design founded?

    Oxford Drug Design was founded in 2001.

  • How much revenue does Oxford Drug Design generate?

    Oxford Drug Design generates $1.4M in revenue.

  • Who is the CEO of Oxford Drug Design

    The CEO of Oxford Drug Design is Graham Richards.

  • How much funding does Oxford Drug Design have?

    Oxford Drug Design raised $12.4M.

  • How many employees does Oxford Drug Design have?

    Oxford Drug Design has 11 employees.

  • Where is Oxford Drug Design headquarters?

    Oxford Drug Design is headquartered at Oxford, United Kingdom

People Also Viewed

Homads

Developer of an online real estate platform designed to recommend renters to quality neighborhoods based on who they are. The company's online real estate platform connects users to midterm rentals during their housing transition and takes a fee from each month booked, enabling renters to efficiently learn and test their neighborhoods

ftrack

Provider of a project management platform designed to streamline coordination in media production. The company's platform features view options to highlight milestones at the project, team or studio level, and tools to create review points that increase visibility and collaboration with clients, enabling creative production studios to improve their efficiency and take on more complex projects.

DEARhealth

Developer of an AI-powered platform intended to significantly improve the health outcomes and experience of chronically ill patients. The company's platform uses advanced data analytics to drive disease-specific, coordinated care pathways with streamlined provider workflows, patient apps and organizational decision support, enabling health care providers to improve patient experience and measurable health outcomes at lower costs.

Kitchen CUT

Kitchen CUT is a complete digital kitchen management system designed to manage dish costing, cost tracking, and day to day back office kitchen operations. It empowers teams to quickly and accurately create, cost and share dishes, allergens and nutritional analysis while tracking ongoing stock. Wastage, breakages and ordering. F&B teams use Kitchen CUT to quickly and accurately create, cost and share dishes with allergen and nutrition info, produce stock take, wastage and breakage reports and gain vital analytics and insights to make their business more profitable. Our Network products give the ability to generate powerful performance insights and analytics across group businesses while integrating with purchasing and EPOS systems to give you up-to-the minute performance insights across your business.

Plattar

Developer of an augmented reality application. The company develops an application that allows users to create, manage, and share augmented reality content.

ChronicCareIQ

ChronicCareIQ was found by Matt Ethington in 2015. The founder was diagnosed with Type 1 Diabetes at the age of 30, a highly unusual and late diagnosis for a type 1 diabetic. Matt quickly discovered and learned about the patient experience in a chronic care management process and the disconnect between patients and physicians. ChronicCareIQ's enables physicians and hospitals to stay better connected to their patients. CCIQ's connected care platform is an all in one tool-kit for physicians to provide chronic care management, remote patient monitoring, and transitional care management for their patient population. CCIQ is an early warning system to know when fragile and chronic patients require your attention. Patients respond to automated, algorithm driven electronic queries via smart phone app, text, email, desktop or tablet. Queries match patient health profiles and are dynamic to detect disease progression, decompensation, change in symptoms and patient status. Those, whose resp